Zurueck zur Suche

Reporte zur Charge U024220

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

14Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
TX 7 OK 2 AL 2 FL 2 IL 1

VAERS 2462466

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge u024220

mild
Staat
TX
Alter
1,1
Geschlecht
M
Eingang
27.09.2022
Impfdatum
15.09.2022
Beginn
26.09.2022
Tage bis Beginn
11,0
Dosis
1
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Rash maculo-papular

Symptomtext

Maculopapular Rash through out body. Treatment: Cetirizine oral solution 2.5 ml daily Outcome: Stable Date of visit 9/27/2022

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash maculo-papular
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
Diaper Rash
Vorgeschichte
No
Andere Medikamente
Tylenol 160/5 3.75 ml
Allergien
NKA
Vorherige Impfungen
-

VAERS 2283172

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge u024220

mild
Staat
TX
Alter
1,6
Geschlecht
M
Eingang
18.05.2022
Impfdatum
04.05.2022
Beginn
05.05.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Pyrexia Rash macular Varicella

Symptomtext

On 5/5/22 , 1 day after the vaccines were given, red dots appeared all over the patients body, face and hands. Mom stated it looked like a Varicella outbreak. He also had fever. This continued for 3 days then it went away on its own.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pyrexia
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2157708

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U024220

mild
Staat
IL
Alter
38,0
Geschlecht
F
Eingang
04.03.2022
Impfdatum
02.03.2022
Beginn
03.03.2022
Tage bis Beginn
1,0
Dosis
UNK
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site erythema Injection site induration Injection site swelling Injection site warmth

Symptomtext

PT NOTICED REDDENED AREA AROUND INJECTION SITE APPROX 30 HOURS AFTER INJECTION. SHE CIRCLED RED AREA. THE NEXT MORNING, THE SITE HAD MORE THAN DOUBLED IN SIZE, FELT HARD AND WARM TO TOUCH. PT WAS LOOKED AT BY ONE OF THE PROVIDERS IN THE OFFICE (PT IS EMPLOYED AT PEDIATRIC OFFICE). MAY BEGIN ANTIBIOTICS FOR POSSIBLE CELLULITIS

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
PT DID RECEIVE COVID 19 BOOSTER ON SAME DAY IN SAME ARM
Allergien
-
Vorherige Impfungen
-

VAERS 2124198

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U024220

mild
Staat
TX
Alter
1,0
Geschlecht
F
Eingang
18.02.2022
Impfdatum
16.02.2022
Beginn
16.02.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Asthenia Cough Irritability Urticaria Vomiting

Symptomtext

Infant developed hives ~ 3 hours after vaccination. Noted only on lower extremities on the day of vaccination 2/16/22. No hives on body or face, no lip or eye swelling, no coughing, runny nose, or congestion. She started vomiting when she was given solids at dinnertime on day of vaccination. Mom notes coughing preceded vomiting. Infant able to keep her formula and liquids down without vomiting. Yesterday, noted to be "weaker", not wanting to walk as much, hives worsened on the legs. No hives on the body noted. Still without fever. Infant seen in the office today (2/18/22) @ 12pm with 1 small area of urticaria on left lateral thigh, few flat patches on lower leg bilaterally. No wheezing noted, no lip/eye swelling. Infant was fussy, but consolable. No altered mental status appreciated on exam.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Urticaria
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
subjective warmth the day prior to vaccination
Vorgeschichte
none
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 2683232

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U024220

gering
Staat
OK
Alter
-
Geschlecht
U
Eingang
18.09.2023
Impfdatum
30.08.2023
Beginn
30.08.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No additional AE/PQC; patient was administered an expired dose of VARIVAX; This spontaneous report was received from a registered nurse concerning a patient of unknown age and gender. Their concurrent conditions, medical history, drug reactions/allergies, and concomitant medications were not provided. On 30-AUG-2023, the patient was vaccinated with and expired dose of varicella virus vaccine live (Oka/Merck) (VARIVAX) injection, 0.5 ml, lot number U024220 with expiration date 04-AUG-2023, administered as prophylaxis (Expired product administered) (dosage regimen and route of administration were not reported). According to the reporter, the dose was considered as supported based on the Post Expiry Memo, the registered nurse was "happy" with the outcome and did not request. No additional adverse event was reported (No adverse event).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2682641

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge u024220

gering
Staat
OK
Alter
-
Geschlecht
U
Eingang
15.09.2023
Impfdatum
-
Beginn
30.08.2023
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No additional AE/PQC.; the patient was administered an expired dose of VARIVAX; Information has been received from a registered nurse, referring to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 30-AUG-2023, the patient was vaccinated with an expired dose of varicella virus vaccine live (oka/merck) (VARIVAX) injection, 0.5 milliliter, lot #u024220, expiration date: 04-AUG-2023, administered for prophylaxis (strength, and route of administration were not provided). No adverse effects were reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2429187

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U024220

gering
Staat
TX
Alter
-
Geschlecht
U
Eingang
06.09.2022
Impfdatum
-
Beginn
16.08.2022
Tage bis Beginn
-
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

Caller reported vaccine administered after temperature excursions; This spontaneous report has been received from a medical assistant concerning a patient of unknown age and gender. The patient's medical history, drug reactions or allergies, concurrent conditions and concomitant medications were not reported. On an unknown date, a temperature excursion occurred for varicella virus vaccine live (oka/merck) (VARIVAX) in which the maximum temperature was 10.9 degrees Fahrenheit for a time frame of 1 hours and 25 minutes. There were not previous temperature excursions. On 16-AUG-2022, the patient was vaccinated with a dose of varicella virus vaccine live (oka/merck) (VARIVAX) 0,5 ml, administered subcutaneous, lot # U024220, expiration date 04-AUG-2023 (anatomical location was not provided) for prophylaxis (product storage error). This is one of multiple reports from the same reporter.; Sender's Comments: US-009507513-2209USA000437: US-009507513-2209USA000438:

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2406554

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U024220

gering
Staat
TX
Alter
-
Geschlecht
U
Eingang
10.08.2022
Impfdatum
03.08.2022
Beginn
03.08.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Accidental underdose No adverse event

Symptomtext

No adverse event; VARIVAX may have accidentally pushed out some of the vaccine prior to administration thus administering less than the full 0.5 mL dose to patient; This spontaneous report was received from a physician and refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history, allergies and concomitant therapies were not reported. On 03-AUG-2022, the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) 0.5 milliliter (ml), lot #U024220, expiration date: 04-AUG-2023, administered for prophylaxis (strength, and route of administration were not provided); which had been diluted with sterile diluent, lot #T032311, expiration date: 05-MAY-2023. It was reported that the medical assistant who administered varicella virus vaccine live (oka/merck) (VARIVAX) to the patient might had accidentally pushed out some of the vaccine prior to administration thus administering less than 0.5 ml dose to the patient. The reported stated that the patient might had received 0.3 ml or 0.4 ml (accidental underdose). No adverse event was reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Accidental underdose
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
STERILE DILUENT
Allergien
-
Vorherige Impfungen
-

VAERS 2323697

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U024220

gering
Staat
AL
Alter
-
Geschlecht
U
Eingang
18.06.2022
Impfdatum
06.05.2022
Beginn
06.05.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AEs or PQC reported; vaccine administered after temperature excursion; This spontaneous report was received from a registered nurse, referring to a patient of unknown age and gender. The patient's pertinent medical history, drug reactions/allergies and concomitant therapies were not provided. On 06-MAY-2022, the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) (lot # U024220, expiration date was reported as 03-AUG-2023 but upon internal validation established as 04-AUG-2023, 0.5 milliliter; strength and dose number were not reported) subcutaneously(SQ) for prophylaxis after temperature excursion (product storage error). The storage temperature of the vaccine was 10 degrees Fahrenheit (F) for a time frame of 14 minutes. There was no previous temperature excursion. No additional adverse event (AE) or product quality complaint (PQC) reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2321434

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U024220

gering
Staat
AL
Alter
-
Geschlecht
U
Eingang
16.06.2022
Impfdatum
10.05.2022
Beginn
10.05.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

no AE; Caller reports vaccine administered after temperature excursion; This spontaneous report has been received from a nurse referring to a patient of unknown gender and age. The patient's medical history, concurrent condition, drug reactions/allergies, and concomitant therapy were not provided. On 10-MAY-2022, the patient was vaccinated with varicella virus vaccine live (Oka/Merck) (VARIVAX) after temperature excursion 0.5 ml, subcutaneous (SQ) (strength not provided, lot number U024220 has been verified to be a valid lot number, expiration date reported as 03-AUG-2023, but upon internal validation was established as 04-AUG-2023) for prophylaxis (product storage error). The temperature was 10 Fahrenheit with a time frame of 14 minutes. There was no previous temperature excursion. No additional adverse events (no adverse event).

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2302885

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U024220

gering
Staat
FL
Alter
-
Geschlecht
U
Eingang
31.05.2022
Impfdatum
13.05.2022
Beginn
13.05.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AE's and no PQC's were reported; an improperly stored dose of VARIVAX was administered to a patient; This spontaneous report has been received from a registered nurse concerning a patient of unreported age and gender. The patient's pertinent medical history, concurrent conditions, drug reactions, or allergies, and concomitant medications were not provided. On 13-MAY-2022, the patient was administered vaccine varicella virus vaccine live (oka/merck) (VARIVAX) 1 dose, vial (valid lot number U024220 (also reported as U024229) [expiration date 04-AUG-2023]) for prophylaxis (reported as use as directed to prevent varicella infection), after a temperature excursion of 32.9 degrees Fahrenheit (F) for 24 hours (h) 30 minutes (min) and 0 seconds (sec) (product storage error) (dose, dose number, vaccination scheme frequency, route, and anatomical location of vaccination were not provided). No previous temperature excursion was reported. No additional adverse events (AE) were reported. This is one of some cases from same reporter.; Sender's Comments: US-009507513-2205USA004149:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2290226

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U024220

gering
Staat
FL
Alter
-
Geschlecht
U
Eingang
23.05.2022
Impfdatum
-
Beginn
13.05.2022
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AE's; The nurse reported an improperly stored dose of VARIVAX was administered to a patient; This spontaneous report has been received from a nurse concerning a patient of unreported age and gender. The patient's pertinent medical history, concurrent conditions, drug reactions, or allergies, and concomitant medications were not provided. On 13-MAY-2022, the patient was administered vaccine varicella virus vaccine live (oka/merck) (VARIVAX) 1 dose, vial (valid lot number U024220 [expiration date 04-AUG-2023]) for prophylaxis, after a temperature excursion of 32.9 degrees Fahrenheit (F) for 24 hours (h) 30 minutes (min) and 0 seconds (sec) (product storage error) (dose, dose number, vaccination scheme frequency, route, and anatomical location of vaccination were not provided). No previous temperature excursion was reported. No additional adverse events (AE) were reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2286347

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U024220

gering
Staat
TX
Alter
1,1
Geschlecht
F
Eingang
20.05.2022
Impfdatum
18.04.2022
Beginn
18.04.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No adverse event; VARIVAX was administered after a temperature excursion; This spontaneous report was received from a medical assistant referring to a 13-month-old female patient. The patient's medical history and concurrent conditions were not reported. Concomitant medications included measles (+) mumps (+) and rubella (wistar ra 27-3) virus vaccine (+) live recombinant human albumin (rha) (M-M-R II). On 18-APR-2022, the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX), at a dose of 0.5 milliliters (ml), administered subcutaneously (SQ) (lot number U024220 has been verified to be valid, expiration date reported and established as 04-AUG-2023; formulation, strength, and anatomical location were not provided) for prophylaxis. The administered dose of the suspect vaccine experienced a temperature excursion of 41 degrees Fahrenheit (?F) for 8 hours, 20 minutes, and 0 seconds (product storage error). There was no previous temperature excursion. No additional adverse events (AE) were reported (no adverse event).

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2272986

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge u024220

gering
Staat
TX
Alter
1,8
Geschlecht
U
Eingang
12.05.2022
Impfdatum
31.03.2022
Beginn
31.03.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Extra dose administered No adverse event

Symptomtext

No additional adverse events were reported; Patient received VARIVAX and PROQUAD together; This spontaneous report was received from a registered nurse referring to a 21-month-old, patient of unknown gender, whose medical history, concurrent conditions, and concomitant therapies were not provided. On 31-MAR-2022, the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, dose reported as 1 dose, administered for prophylaxis (lot number: u024220, has been verified to be a valid lot number, and expiration date: 04-AUG-2023; exact dose, vaccination scheme frequency, route of administration, and anatomical location were not provided); it was administered together with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) subcutaneous injection, for prophylaxis (exact dose, vaccination scheme frequency, route of administration, anatomical location, lot number, and expiration date were not provided) (overdose). No additional adverse events were reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-